243 related articles for article (PubMed ID: 24273180)
1. Amelioration of Cryptosporidium parvum infection in vitro and in vivo by targeting parasite fatty acyl-coenzyme A synthetases.
Guo F; Zhang H; Fritzler JM; Rider SD; Xiang L; McNair NN; Mead JR; Zhu G
J Infect Dis; 2014 Apr; 209(8):1279-87. PubMed ID: 24273180
[TBL] [Abstract][Full Text] [Related]
2. Identification of adaptive inhibitors of Cryptosporidium parvum fatty acyl-coenzyme A synthetase isoforms by virtual screening.
Chattopadhyay S; Mahapatra RK
Parasitol Res; 2019 Nov; 118(11):3159-3171. PubMed ID: 31486948
[TBL] [Abstract][Full Text] [Related]
3. Triacsin C: a differential inhibitor of arachidonoyl-CoA synthetase and nonspecific long chain acyl-CoA synthetase.
Hartman EJ; Omura S; Laposata M
Prostaglandins; 1989 Jun; 37(6):655-71. PubMed ID: 2505330
[TBL] [Abstract][Full Text] [Related]
4. Characterization of triacsin C inhibition of short-, medium-, and long-chain fatty acid: CoA ligases of human liver.
Vessey DA; Kelley M; Warren RS
J Biochem Mol Toxicol; 2004; 18(2):100-6. PubMed ID: 15122652
[TBL] [Abstract][Full Text] [Related]
5. Human intestinal acyl-CoA synthetase 5 is sensitive to the inhibitor triacsin C.
Kaemmerer E; Peuscher A; Reinartz A; Liedtke C; Weiskirchen R; Kopitz J; Gassler N
World J Gastroenterol; 2011 Nov; 17(44):4883-9. PubMed ID: 22171129
[TBL] [Abstract][Full Text] [Related]
6. Evidence for an essential role of long chain acyl-CoA synthetase in animal cell proliferation. Inhibition of long chain acyl-CoA synthetase by triacsins caused inhibition of Raji cell proliferation.
Tomoda H; Igarashi K; Cyong JC; Omura S
J Biol Chem; 1991 Mar; 266(7):4214-9. PubMed ID: 1999415
[TBL] [Abstract][Full Text] [Related]
7. Anti-atherosclerotic activity of triacsin C, an acyl-CoA synthetase inhibitor.
Matsuda D; Namatame I; Ohshiro T; Ishibashi S; Omura S; Tomoda H
J Antibiot (Tokyo); 2008 May; 61(5):318-21. PubMed ID: 18653998
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous long chain acyl-CoA synthetases control distribution of individual fatty acids in newly-formed glycerolipids of neuronal cells undergoing neurite outgrowth.
Li J; Wurtman RJ
Neurochem Res; 1999 Jun; 24(6):739-50. PubMed ID: 10447457
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the reactivity of tetradecenoic acids, a triacsin, and unsaturated oximes with four purified Saccharomyces cerevisiae fatty acid activation proteins.
Knoll LJ; Schall OF; Suzuki I; Gokel GW; Gordon JI
J Biol Chem; 1995 Aug; 270(34):20090-7. PubMed ID: 7650027
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of acyl-CoA synthetase by triacsins.
Tomoda H; Igarashi K; Omura S
Biochim Biophys Acta; 1987 Oct; 921(3):595-8. PubMed ID: 3117118
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum.
Nava MG; Calderón F; Fernández E; Ballell L; Bamborough P; Vinayak S
Microbiol Spectr; 2023 Feb; 11(1):e0387422. PubMed ID: 36533912
[TBL] [Abstract][Full Text] [Related]
12. Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum.
Li K; Nader SM; Zhang X; Ray BC; Kim CY; Das A; Witola WH
PLoS Pathog; 2019 Jul; 15(7):e1007953. PubMed ID: 31356619
[TBL] [Abstract][Full Text] [Related]
13. Long chain acyl coenzyme A and signaling in neutrophils. An inhibitor of acyl coenzyme A synthetase, triacsin C, inhibits superoxide anion generation and degranulation by human neutrophils.
Korchak HM; Kane LH; Rossi MW; Corkey BE
J Biol Chem; 1994 Dec; 269(48):30281-7. PubMed ID: 7982939
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting long-chain fatty acyl CoA synthetase does not increase agonist-induced release of arachidonate metabolites from human endothelial cells.
Weis MT; Brady M; Moore M; Crumley J; Stallone JN
J Vasc Res; 2005; 42(4):275-83. PubMed ID: 15908751
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a Cryptosporidium parvum gene encoding a protein with homology to long chain fatty acid synthetase.
Camero L; Shulaw WP; Xiao L
J Eukaryot Microbiol; 2003; 50 Suppl():534-8. PubMed ID: 14736154
[TBL] [Abstract][Full Text] [Related]
16. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
Morales Gomez MA
Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
[TBL] [Abstract][Full Text] [Related]
17. The acyl-CoA synthetase inhibitor triacsin C enhanced eicosanoid release in leukocytes.
Oh-ishi S; Yamaki K; Abe M; Tomoda H; Omura S
Jpn J Pharmacol; 1992 Jul; 59(3):417-8. PubMed ID: 1434135
[TBL] [Abstract][Full Text] [Related]
18. p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.
Mashima T; Oh-hara T; Sato S; Mochizuki M; Sugimoto Y; Yamazaki K; Hamada J; Tada M; Moriuchi T; Ishikawa Y; Kato Y; Tomoda H; Yamori T; Tsuruo T
J Natl Cancer Inst; 2005 May; 97(10):765-77. PubMed ID: 15900046
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Acyl-CoA synthetase activity of purified murine fatty acid transport protein 1.
Hall AM; Smith AJ; Bernlohr DA
J Biol Chem; 2003 Oct; 278(44):43008-13. PubMed ID: 12937175
[TBL] [Abstract][Full Text] [Related]
20. Morpholino-mediated in vivo silencing of Cryptosporidium parvum lactate dehydrogenase decreases oocyst shedding and infectivity.
Zhang X; Kim CY; Worthen T; Witola WH
Int J Parasitol; 2018 Jul; 48(8):649-656. PubMed ID: 29530646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
